This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Hooper Holmes Announces Second Quarter 2012 Results

Hooper Holmes (NYSE MKT:HH) today announced financial results for the quarter ended June 30, 2012.

Consolidated revenues totaled $35.4 million for the second quarter of 2012, representing a 7% decline from $37.9 million in the second quarter of 2011. The Company recorded a net loss of $5.5 million, or ($0.08) per share, for the second quarter of 2012 compared to a net loss of $1.6 million, or ($0.02) per share, for the second quarter of 2011. The net loss for the second quarter of 2012 includes $1.6 million of restructuring charges related to our new Portamedic service delivery model.

For the six months ended June 30, 2012, consolidated revenues were $74.2 million compared to $78.5 million in the comparable period of 2011. The Company’s net loss for the six months ended June 30, 2012 totaled $8.7 million, or ($0.12) per share, compared to a net loss of $1.7 million, or ($0.02) per share, for the six months ended June 30, 2011. The results for the six months ended June 30, 2012 include $2.2 million of restructuring charges, primarily related to our new Portamedic service delivery model.

Second quarter 2012 revenues by service line:

  • Portamedic revenue totaled $24.4 million in the second quarter of 2012, a decline of approximately 9% compared to $26.8 million in the second quarter of 2011, primarily due to an 8% decline in paramedical exams completed during the quarter, along with a 1.9% decrease in revenue per exam.
  • Health & Wellness revenue totaled $3.8 million for the second quarter of 2012, a 51% increase from the second quarter of 2011, primarily due to an increase in health screenings completed during the quarter.
  • Heritage Labs revenue totaled $2.8 million for the second quarter of 2012, a decrease of approximately 10% compared to the second quarter of 2011, primarily attributable to a decrease in revenue from the Company’s lab kit assembly services.
  • Hooper Holmes Services revenue totaled $4.4 million for the second quarter of 2012, a decrease of 20% in comparison to the prior year period, primarily due to reduced demand for the Company’s medical records collection services.

The Company's cash balance declined by approximately $2.0 million in the second quarter of 2012, primarily attributable to net cash used in operations of approximately $0.9 million and capital expenditures totaling $1.0 million in the second quarter of 2012. As of June 30, 2012, cash and cash equivalents totaled $11.4 million, with no outstanding borrowings under the Company’s credit facility.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs